NCT06825312 - Immunogenicity, Safety, and Antibody Persistence of Different Immunization Strategies Against Japanese Encephalitis | Biotech Hunter

Enrollment

600

Participants

Timeline

Start Date

November 11, 2023

Primary Completion Date

December 31, 2030

Study Completion Date

December 31, 2031

Conditions

Japanese Encephalitis Vaccine

Interventions

BIOLOGICAL

Japanese Encephalitis Vaccine (Vero Cell), Inactivated

0.5ml for each dose, manufactured by Liaoning Chengda Biotechnology Co., Ltd., administered in the deltoid area of lateral arm by intramuscular injection.

BIOLOGICAL

Japanese Encephalitis Vaccine, Live

0.5ml for each dose, manufactured by Chengdu Institute of Biological Products Co., Ltd., administered subcutaneously in the lower part of the deltoid area of lateral arm.

Trial Locations (6)

Unknown

Jiashan County Center for Disease Control and Prevention, Jiaxing

Pinghu Center For Disease Control and Prevention, Jiaxing

Dongyang Center for Disease Control and Prevention, Jinhua

Yongkang Center for Disease Control and Prevention, Jinhua

Yuyao Center for Disease Control and Prevention, Ningbo

Jiangshan Center For Disease Control and Prevention, Quzhou

All Listed Sponsors

collaborator

Zhejiang Provincial Center for Disease Control and Prevention

OTHER_GOV

lead

Liaoning Chengda Biotechnology CO., LTD

INDUSTRY